Evidence map›Paper›PMID 30443886›Full record

ArticleTranslational stroke research2019

Soluble Epoxide Hydrolase-Derived Linoleic Acid Oxylipins in Serum Are Associated with Periventricular White Matter Hyperintensities and Vascular Cognitive Impairment.

Di Yu, Marie Hennebelle, Demetrios J Sahlas, Joel Ramirez, Fuqiang Gao, Mario Masellis, Hugo Cogo-Moreira, Richard H Swartz, Nathan Herrmann, Pak Cheung Chan and 5 more

Abstract read
PubMed Publisher
In one paragraph

Article in Translational stroke research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 2 pooled it
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 2 syntheses or guidelines pooled it, 53 citations in OpenAlex.

  1. Cognitive impairment in sporadic cerebral small vessel disease: A systematic review and meta-analysis.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2021
    Pooled it
  2. Pooled it
  3. The Roles of EETs in Neurological Disorders.CNS neuroscience & therapeutics · 2026
    Review
  4. Impacts of Oxylipins on ischemic stroke: from pathophysiology to clinical phenotypes.Metabolomics : Official journal of the Metabolomic Society · 2025
    Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 4 countries.

Di YuHurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, Canada.
Marie HennebelleDepartment of Food Science and Technology, College of Agriculture and Environmental Sciences, University of California, Davis, CA, USA.
Demetrios J SahlasDepartment of Medicine (Neurology Division), McMaster University, Hamilton, Canada.
Joel RamirezHurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, Canada.
Fuqiang GaoHurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, Canada.
Mario MasellisHurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, Canada.
Hugo Cogo-MoreiraDepartamento Psiquiatria, Universidade Federal de São Paulo, São Paulo, Brazil.
Richard H SwartzHurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, Canada.
Nathan HerrmannHurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, Canada.
Pak Cheung ChanDepartment of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada.
Jacqueline A PettersenDepartment of Medicine (Neurology Division) and the Northern Medical Program, University of British Columbia, Vancouver, Canada.
Donald T StussHurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, Canada.
Sandra E BlackHurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, Canada.
Ameer Y TahaDepartment of Food Science and Technology, College of Agriculture and Environmental Sciences, University of California, Davis, CA, USA.
Walter SwardfagerHurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, Canada. w.swardfager@utoronto.ca.ORCID 0000-0002-0030-8908
Sunnybrook Health Science Centre · CAUniversity of California, Davis · USFreie Universität Berlin · DEMcMaster University · CAUniversity of British Columbia · CA

Funding

CIHR 125740CIHR 13129
6 · The paper itself

Abstract

White matter hyperintensities (WMH) are presumed to indicate subcortical ischemic vascular disease but their underlying pathobiology remains incompletely understood. The soluble epoxide hydrolase (sEH) enzyme converts anti-inflammatory and vasoactive cytochrome p450-derived polyunsaturated fatty acid epoxides into their less active corresponding diol species. Under the hypothesis that the activity of sEH might be associated with subcortical ischemic vascular disease and vascular cognitive impairment, this study aimed to compare the relative abundance of sEH substrates and products in peripheral blood between patients with extensive WMH (discovered due to transient ischemic attack; n = 29) and healthy elderly with minimal WMH (n = 25). The concentration of 12,13-DiHOME (a sEH-derived linoleic acid metabolite), and the ratio of 12,13-DiHOME to its sEH substrate, 12,13-EpOME, were elevated in the extensive WMH group (F

Indexed as

AgedBiomarkersCerebral VentriclesCognitive DysfunctionCross-Sectional StudiesEpoxide HydrolasesFemaleHumansLinoleic AcidMaleOxylipinsVascular DiseasesWhite MatterBiomarkersEpoxide HydrolasesLinoleic AcidOxylipinsLinoleic acidOxylipinsSmall vessel diseaseSoluble epoxide hydrolaseVascular cognitive impairment

Identifiers

PMID30443886
OpenAlexW2901188304

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.